Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Pfizer’s COVID pill reportedly offered no measurable benefit for adults 40 to 65, according to a study published on Wednesday.

The Israeli study was conducted among 109,000 patients who were 40 years old or older.

READ MORE
 

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

EU Members Agree to Lift Travel Restrictions on U.S. Tourists

The European Union is recommending the use of digital travel…
Read more
Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Southern Baptists Elect New President: Critical Race Theory Still a Hot Button Issue

Pastor Ed Litton of Alabama has been elected President of…
Read more

Naftali Bennet Speaks with Ukrainian President

Israel's brand new Prime Minister, Naftali Bennett, spoke…
Read more